CLAUPAREST
CLAUPAREST is an FDA drug label for the active ingredient ARANEUS DIADEMATUS, ARNICA MONTANA ROOT, CUPRIC ACETATE, MANDRAGORA OFFICINARUM ROOT, LEAD ACETATE ANHYDROUS, TOBACCO LEAF, MELILOTUS OFFICINALIS TOP, AND RUTA GRAVEOLENS FLOWERING TOP manufactured by PEKANA Naturheilmittel GmbH administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20221206.
- Generic name
- ARANEUS DIADEMATUS, ARNICA MONTANA ROOT, CUPRIC ACETATE, MANDRAGORA OFFICINARUM ROOT, LEAD ACETATE ANHYDROUS, TOBACCO LEAF, MELILOTUS OFFICINALIS TOP, AND RUTA GRAVEOLENS FLOWERING TOP
- Manufacturer
- PEKANA Naturheilmittel GmbH
- Product type
- HUMAN OTC DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 59469-143
- Application
- N/A
- Label effective
- 20221206
Active ingredients
Indications & Usage
Indications For relief of minor lower body stiffness and pain. Application of this homeopathic remedy for the designated usage is exclusively based on homeopathic experience. With severe forms of this disease, a clinically proven therapy is indicated.
Dosage & Administration
Dosage Unless otherwise prescribed, adults take 15-20 drops, 3 times per day. For pediatric dosages, consult your practitioner.
Contraindications
Not available.
Warnings
Warning If symptoms persist, contact a licensed practitioner. If you have known sensitivity to any of the ingredients, please consult your licensed practitioner before use. If you are pregnant or nursing a baby, seek the advice of a health care professional before use. Keep out of the reach of children.
Adverse Reactions
Not available.